You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Gleason Score

Showing 1 - 25 of 8,295
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Failure in Patients Undergoing Radiation Therapy for Localized

Active, not recruiting
  • Prostate Cancer
  • Radiation Toxicity
  • medical chart review
  • +4 more
  • San Francisco, California
    University of California, San Francisco
Dec 9, 2022

Prostate Cancer Upgrading Reference Set

Recruiting
  • Prostate Cancer
    • San Antonio, Texas
      University of Texas Health Science Center at San Antonio
    Mar 30, 2022

    Tumor Recurrence Following Radiotherapy

    Recruiting
    • Prostate Cancer
      • Rochester, Minnesota
        Mayo Clinic
      Jan 20, 2023

      Localized Prostate Cancer Trial in New York (TOOKAD Soluble 4 mg/kg)

      Active, not recruiting
      • Localized Prostate Cancer
      • TOOKAD Soluble 4 mg/kg
      • New York, New York
        Memorial Sloan-Kettering Cancer Center
      May 3, 2022

      In Situ Clonal Heterogeneity in Prostatic Diagnostic Biopsies

      Recruiting
      • Prostate Cancer
      • Genetic Predisposition
      • clonal heterogeneity evaluation
      • Lugano, Ticino, Switzerland
        Alessandra Franzetti Pellanda
      Jul 19, 2022

      Prostate Cancer Stage I Trial in Torino (Katty focal therapy)

      Completed
      • Prostate Cancer Stage I
      • Katty focal therapy
      • Torino, TO, Italy
        A.O.U. San Giovanni Battista Molinette
      Jan 31, 2023

      Prostate Cancer Trial in New York (Dose escalation)

      Recruiting
      • Prostate Cancer
      • Dose escalation
      • New York, New York
        Weill Cornell Medicine
      Jul 29, 2022

      Prostate Cancer Trial in Montreal (18F-DCFPyL PET/CT)

      Completed
      • Prostate Cancer
      • 18F-DCFPyL PET/CT
      • Montreal, Quebec, Canada
        Jewish General Hospital
      Feb 12, 2019

      Oncology, Prostate Cancer Trial in Edmonton ([18]F-PSMA-1007)

      Not yet recruiting
      • Oncology
      • Prostate Cancer
      • Edmonton, Alberta, Canada
        Cross Cancer Institute
      Jan 25, 2023

      Positron Emission Radiomics With PSMA Radioligands on Newly

      Not yet recruiting
      • Prostate Cancer
      • Immunohistochemistry (IHC) analysis
      • (no location specified)
      Apr 6, 2023

      Prostate Cancer Trial in Zurich ([68Ga]PSMA-11, [18F]PSMA-1007)

      Completed
      • Prostate Cancer
      • Zurich, Switzerland
        University Hospital Zurich
      Aug 27, 2021

      Integrated Genomic Prostate Score With MRI Targeted Prostate

      Active, not recruiting
      • Prostate Cancer
        • Birmingham, Alabama
        • +1 more
        Jan 12, 2023

        Race-related Alternative Splicing: Novel Targets in Prostate

        Completed
        • Prostate Cancer
        • No interventions - retrospective data collection
        • Durham, North Carolina
          Duke University Medical Center
        Feb 1, 2022

        Prostate Cancer Trial in Stanford, Bordeaux (BR55)

        Completed
        Has Results
        • Prostate Cancer
        • Stanford, California
        • +1 more
        Mar 2, 2021

        Prostate Cancer, Elevated PSA Trial in New York (prostate biopsy)

        Terminated
        Has Results
        • Prostate Cancer
        • Elevated PSA
        • prostate biopsy
        • New York, New York
          Weill Cornell Medicine
        Jun 21, 2021

        Prostate Cancer Trial in Baltimore (Enoblituzumab, Standard of Care)

        Not yet recruiting
        • Prostate Cancer
        • Baltimore, Maryland
          Johns Hopkins Sidney Kimmel Comprehensive Cancer Center
        Aug 25, 2023

        18F Prostate-specific Membrane Antigen PET/CT in Prostate Cancer

        Recruiting
        • Prostatic Neoplasms
        • Positron emission tomography/computerized tomography (PET/CT)
        • Xi'an, Shaanxi, China
          First Affiliate Hospital of Xi'an Jiaotong University
        Mar 23, 2022

        Ultrasound Radiomics in Ultrasound Fusion Targeted Prostate

        Not yet recruiting
        • Prostate Cancer
        • +2 more
          • (no location specified)
          Feb 27, 2023

          Non-Invasive Biomarkers in Prostate Cancer Disease Management

          Recruiting
          • Prostate Cancer
          • Genomic and Histological Evaluation
          • Tampa, Florida
            Moffitt Cancer Center
          Nov 16, 2023

          Prostate Cancer, Prostate Adenocarcinoma, Prostate Tumor Trial in London (PET Scan, [F-18]-DCFPyL Injection, Sodium MRI)

          Recruiting
          • Prostate Cancer
          • +2 more
          • PET Scan
          • +3 more
          • London, Ontario, Canada
            London Health Sciences Centre
          Dec 6, 2021

          Prostate Cancer Trial in Beijing (Target biopsies, systemic biopsies)

          Not yet recruiting
          • Prostate Cancer
          • Target biopsies
          • systemic biopsies
          • Beijing, Beijing, China
            Peking University Cancer Hospital &institute
          Jul 17, 2023

          Prostate Cancer Trial in Durham (Acoustic radiation force impulse (ARFI), Ultrasound)

          Recruiting
          • Prostate Cancer
          • Acoustic radiation force impulse (ARFI)
          • Ultrasound
          • Durham, North Carolina
            Duke University Medical Center
          Jan 23, 2023

          Prostate Cancer, Prostate Tumor Trial in Winston-Salem (Blood draws, Magnetic resonance imaging (MRI))

          Withdrawn
          • Prostate Cancer
          • Prostate Tumor
          • Blood draws
          • Magnetic resonance imaging (MRI)
          • Winston-Salem, North Carolina
            Wake Forest Baptist Comprehensive Cancer Center
          Nov 17, 2021

          Prostate Cancer Trial in San Francisco (Pyruvate (13C), Hyperpolarized 13C,15N2-urea, Magnetic Resonance Spectroscopic Imaging)

          Active, not recruiting
          • Prostate Cancer
          • Pyruvate (13C)
          • +2 more
          • San Francisco, California
            University of California, San Francisco
          May 16, 2022

          Prostate Carcinoma Trial in Chicago (Fluorine F 18 DCFPyL, Gadobenate Dimeglumine, Gadobutrol)

          Not yet recruiting
          • Prostate Carcinoma
          • Fluorine F 18 DCFPyL
          • +6 more
          • Chicago, Illinois
            Northwestern University
          Aug 2, 2022